Patent · US Active

EGFR gene expression-suppressing siRNA, precursor of same, and applications thereof

US11304970B2 · kind B2 · utility

0Cited by
1References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 5, 2017
Grant dateApr 19, 2022
Priority date—
Expiry dateMay 5, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are an EGFR gene expression-suppressing siRNA, a precursor sequence of same, and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.